Top Markets
Coin of the day
Sigyn Therapeutics, Inc. Sigyn Therapeutics, Inc.

Sigyn Therapeutics, Inc.

SIGY
Clasificación en acciones #41132
Sigyn Therapeutics, Inc. operates as a therapeutic technology enterprise... Sigyn Therapeutics, Inc. operates as a therapeutic technology enterprise currently in its development phase. The company's core innovation is Sigyn Therapy, an advanced blood purification system designed to overcome the limitations of existing drugs and medical devices used to treat severe inflammatory disorders. A key focus is on sepsis, which represents a major cause of hospital-related deaths. Furthermore, Sigyn Therapeutics is actively evaluating the potential of Sigyn Therapy to address a broad spectrum of other therapeutic targets, including bacterial endotoxins, peptidoglycan, and lipoteichoic acid; various viral pathogens; harmful hepatic toxins; CytoVesicles; and significant pro-inflammatory cytokines such as tumor necrosis factor alpha, interleukin-1 beta, and interleukin 6. The company is headquartered in San Diego, California.
Precio por acción
$0.025
Última sincronización: 2026-08-12
Capitalización bursátil
$40.14K
Cambio (1 día)
-35.90%
Cambio (1 año)
-99.11%
País
US
Comercio Sigyn Therapeutics, Inc. (SIGY)

Categoría

EPS de Sigyn Therapeutics, Inc. (SIGY)
EPS a fecha de 2026 TTM: 0
Según los últimos informes financieros y el precio de las acciones de Sigyn Therapeutics, Inc., el EPS actual de la empresa (TTM) es 0. Al final del año 2026, la empresa tenía un EPS de 0 igual a al EPS de 2026, que fue de 0.
Historial de EPS de Sigyn Therapeutics, Inc. desde 2026 hasta 2026
EPS al final de cada año
Año EPS Cambiar
Not enough data for the provided dates.
EPS de empresas similares o competidoras
Empresa EPS Diferencia de EPS País
$17.32 -
US
$27.74 -
NL
- -
CH
- -
KR
$13.70 -
BE